Aquaretic effect of a potent, orally active, nonpeptide V2 antagonist in men

Journal of Pharmacology and Experimental Therapeutics

Volumn 272, Issue 2, 1995, Pages 546-551

  Ohnishi, A ^a   Orita, Y ^a   Takagi, N ^a   Fujita, T ^a   Toyoki, T ^a   Ihara, Y ^a   Yamamura, Y ^a   Inoue, T ^a   Tanaka, T ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MOZAVAPTAN; PLACEBO; VASOPRESSIN; VASOPRESSIN V2 RECEPTOR;

ADULT; ARTICLE; CHLORIDE BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIURESIS; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENCY; HUMAN; HUMAN EXPERIMENT; MALE; MICTURITION; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PLASMA OSMOLALITY; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; URINE OSMOLALITY; VASOPRESSIN BLOOD LEVEL;

ADMINISTRATION, ORAL; ADULT; ARGININE VASOPRESSIN; BENZAZEPINES; DIURETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMODYNAMIC PROCESSES; HUMANS; MALE; OSMOLAR CONCENTRATION; RECEPTORS, VASOPRESSIN;

EID: 0028796361     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)